Language selection

Search

Details for: FRAXIPARINE

Company: ASPEN PHARMACARE CANADA INC.

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02236913FRAXIPARINENADROPARIN CALCIUM9500 UNIT / MLSOLUTIONINTRAVENOUS
02450623FRAXIPARINENADROPARIN CALCIUM9500 UNIT / MLSOLUTIONINTRAVENOUS
02450631FRAXIPARINENADROPARIN CALCIUM9500 UNIT / MLSOLUTIONINTRAVENOUS
02450658FRAXIPARINENADROPARIN CALCIUM9500 UNIT / MLSOLUTIONINTRAVENOUS
02236913FRAXIPARINENADROPARIN CALCIUM9500 UNIT / MLSOLUTIONSUBCUTANEOUS
02450623FRAXIPARINENADROPARIN CALCIUM9500 UNIT / MLSOLUTIONSUBCUTANEOUS
02450631FRAXIPARINENADROPARIN CALCIUM9500 UNIT / MLSOLUTIONSUBCUTANEOUS
02450658FRAXIPARINENADROPARIN CALCIUM9500 UNIT / MLSOLUTIONSUBCUTANEOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Regulatory Decision Summary
Summary Safety Review - Low-Molecular-Weight Heparins - Assessing the potential risk of bleeding in or around the spinal cord (Spinal/Epidural Hematoma)

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: